Benzene derivative

a technology of benzene derivatives and derivatives, applied in the field of benzene derivatives, can solve the problems of a large number of nerves at the same time, a single nerve may be damaged, and a large number of nerves may be damaged simultaneously, so as to achieve the effect of potent nerve-protecting and/or-repairing activity

Active Publication Date: 2022-03-01
ONO PHARMA CO LTD
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention compound has the ability to protect and repair nerves, making it useful for treating neuropathy such as peripheral neuropathy.

Problems solved by technology

However, in these sensory nerves, axons, myelin sheaths, Schwann cells or the like may be damaged by a viral infection, a tumor, cancer, diabetes, ischemia, an injury, compression, a drug, a radiotherapy or the like, sometimes inducing various neuropathies including the death of cells and demyelination.
As a result, a correct neurotransmission does not occur in a sensory nerve that undergoes the disorder, resulting in the development of a disease such as hearing loss and neuropathic pain.
In this disease, a single nerve may be damaged, or two or more nerves located in different regions or a large number of nerves may be damaged simultaneously.
The symptoms of this disease include pain in a peripheral region, numbness, burning sensation, decreased joint proprioception, decreased vibratory sense, pain (including neuropathic pain), abnormal sensation, coldness, hot flash and the like, and thus are very complex and varied.
There are known very little chemical substances which are clinically useful as modalities that can act directly on damaged nerve systems.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzene derivative
  • Benzene derivative
  • Benzene derivative

Examples

Experimental program
Comparison scheme
Effect test

example 1

3-(2-hydroxyphenyl)propanoate

[0264]Sulfuric acid (0.26 mL) was added to a solution of 3,4-dihydrocoumarin (50.0 g) in isopropyl alcohol (500 mL), and the reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under a reduced pressure, and the resultant residue was diluted with ethyl acetate. The solution was washed with a saturated aqueous sodium bicarbonate solution, water and saturated saline, was then dried over sodium sulfate, and was then concentrated under a reduced pressure. In this manner, the title compound (73.2 g) having the physical property values shown below was produced.

[0265]1H-NMR (CDCl3): δ 1.20, 2.66-2.70, 2.87-2.91, 4.95-5.08, 6.86-6.91, 7.06-7.15, 7.35.

example 2

3-(2-(2-(1,3-dioxan-2-yl)ethoxy)phenyl)propanoate

[0266]Potassium phosphate (2.85 g) was added to a solution of the compound produced in Example 1 (2.00 g) and 2-(2-bromoethyl)-1,3-dioxane (2.43 g) in DMF (4 mL), and the reaction mixture was stirred at 70° C. for 2 hours. The reaction mixture was poured into 1 M hydrochloric acid, and the resultant solution was extracted with ethyl acetate. An organic layer was washed with water and saturated saline, was then dried over sodium sulfate, and was then concentrated under a reduced pressure. The resultant residue was purified by silica gel column chromatography (hexane:ethyl acetate=95:5→4:1). In this manner, the title compound (2.73 g) having the physical property value shown below was produced.

[0267]TLC: Rf 0.57 (hexane:ethyl acetate=2:1).

example 3

3-(2-(3-oxopropoxy)phenyl)propanoate

[0268]A solution of the compound produced in Example 2 (500 mg) and lutidine (0.40 ml.) in dichloromethane (1.5 mL) was cooled to −15° C., and trimethylsilyltrifluoromethanesulfonate (0.42 mL) was added to the solution. The resultant reaction mixture was stirred at 0° C. for 2 hours. Ice (10 g) was added to the reaction solution, and the resultant solution was stirred at 0° C. for 15 minutes. Water and ethyl acetate were added to the solution, the resultant solution was stirred at 0° C. for 20 hours, the resultant reaction mixture was poured into 1 M hydrochloric acid and ethyl acetate, and the resultant solution was extracted with ethyl acetate. An organic layer was washed with water and saturated saline, was then dried over sodium sulfate, and was then concentrated under a reduced pressure. In this manner, the title compound (443 mg) having the physical property values shown below was produced.

[0269]1H-NMR (CDCl3): δ 1.20, 2.50-2.55, 2.93-2.96, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

A compound represented by general formula (I) (in the formula, all symbols are as described in the description) or a salt thereof has a potent nerve-protecting and / or -repairing activity, and therefore can be used as a therapeutic agent for neuropathy (e.g., chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, periarteritis nodosa, allergic vasculitis, diabetic peripheral neuropathy, entrapment neuropathy, peripheral neuropathy associated with the administration of a chemotherapeutic drug, or peripheral neuropathy associated with Charcot-Marie-Tooth disease).

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application claims priority under 37 U.S.C. § 371 to International Patent Application No. PCT / JP2019 / 029883, filed Jul. 30, 2019, which claims priority to and the benefit of Japanese Patent Application No. 2018-143024, filed on Jul. 31, 2018. The contents of these applications are hereby incorporated by reference in their entireties.TECHNICAL FIELD[0002]The present invention relates to a compound represented by general formula (I):[0003][0004](wherein all symbols have the same meanings as described below) or a salt thereof (wherein the compound or the salt thereof is sometimes referred to as “the compound of the present invention”, hereinafter).BACKGROUND ART[0005]Nervous systems are roughly classified into central nervous systems and peripheral nervous systems. Particularly peripheral nervous systems allow the communication of brain and spinal cord with peripheral regions of a body and are therefore involved in neural transmi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(United States)
IPC IPC(8): C07C311/21
CPCC07C311/21A61P25/00C07C311/14C07D209/08C07D209/44C07D213/71C07D215/58C07D217/08C07D277/24C07D295/185C07D305/06C07D307/14C07D333/62A61K45/06C07D213/76C07D333/34C07D307/82C07D309/08C07D309/04C07C2601/08C07B2200/07C07C59/68A61K31/192C07C59/64A61K31/196A61K31/18A61K31/425C12N5/0622C12N2501/999
InventorNOJIMA, SHOJISASAKI, KENJIKAMBE, TOHRUKONEMURA, TAKASHIGOTO, YOSHIKAZU
OwnerONO PHARMA CO LTD